Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth

Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries. The results, which can lead to the immediate treatment of PPCM in new mothers and a significant reduction in mortality, were presented at Heart Failure 2014. Topics: Heart Failure (HF)
Source: ESC News and Press - Category: Cardiology Source Type: news